Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one chemotherapy drug may kill more tumor
cells.
PURPOSE: Phase II trial to study the effectiveness of gemcitabine plus docetaxel in treating
patients who have unresectable or metastatic liver cancer.